Krystal Biotech Soars As Q4 Earnings Put Blockbuster Commercialization In Focus
Krystal Biotech's VYJUVEK sees strong growth with $1B+ 2025 sales forecast. Check out why I rate KRYS as a Strong Buy and my ...
Celsius Stock Soars as Drink Maker Buys Rival, Tops Profit and Sales Estimates
Shares of Celsius Holdings surged 25% Friday, a day after the energy-drink maker bought rival Alani Nu and reported ...